Skip to main content
Print Save

Measles Virus Vaccine / Mumps Virus Vaccine / Rubella Virus Vaccine Dosage

Medically reviewed by Drugs.com. Last updated on Jan 5, 2022.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Mumps Prophylaxis

0.5 mL, subcutaneously, once

Usual Adult Dose for Rubella Prophylaxis

0.5 mL, subcutaneously, once

Usual Adult Dose for Measles Prophylaxis

0.5 mL, subcutaneously, once

Usual Pediatric Dose for Mumps Prophylaxis

12 months of age and older:
0.5 mL, subcutaneously, once

Comments:

  • Primary vaccination is recommended at 12 to 15 months.
  • Revaccination is recommended prior to elementary school entry.
  • Children vaccinated when younger than 12 months should receive another dose at 12 to 15 months of age, as well as revaccination before school entry.

Usual Pediatric Dose for Rubella Prophylaxis

12 months of age and older:
0.5 mL, subcutaneously, once

Comments:

  • Primary vaccination is recommended at 12 to 15 months.
  • Revaccination is recommended prior to elementary school entry.
  • Children vaccinated when younger than 12 months should receive another dose at 12 to 15 months of age, as well as revaccination before school entry.

Usual Pediatric Dose for Measles Prophylaxis

12 months of age and older:
0.5 mL, subcutaneously, once

Comments:

  • Primary vaccination is recommended at 12 to 15 months.
  • Revaccination is recommended prior to elementary school entry.
  • Children vaccinated when younger than 12 months should receive another dose at 12 to 15 months of age, as well as revaccination before school entry.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Measles Outbreak Schedule:
Infants 6 to 12 months of age: If recommended by the local health authority, vaccination may occur in this age range, but should be followed up with another dose at 12 to 15 months of age, and again at 4 to 6 years of age.

Post-Exposure Vaccination:

  • Vaccination after exposure to wild type measles may provide some protection if given within 72 hours of exposure.
  • There is no conclusive evidence that vaccination after exposure to wild type mumps or rubella will provide protection.

Precautions

Safety and efficacy have not been established in patients younger than 12 months.

To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • The outer aspect of the upper arm is the preferred site.
  • Do not administer IV.

Reconstitution/preparation techniques:
  • Use only the supplied diluent.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer